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Summary 
Accumulating evidence has indicated that chronic inflammation is associated with a variety of 
diseases, including cancer, heart attacks, Alzheimer’s and other diseases.  In the cancer 
research field, the association of inflammatory infiltration with cancer has been known 
histologically for a long time.  Recent studies have indicated that macrophages and other 
immune cells infiltrate cancer tissues, expressing cytokines, chemokines and growth factors, 
thereby constructing an inflammatory microenvironment.  In such microenvironment, NF-κB 
is activated, which contributes to the growth and survival of cancer cells.  Moreover, it has 
also been shown that NF-κB activation is associated with the acquisition of stem cell 
properties by cancer cells.  Using inflammation-associated gastric cancer model mice, Gan 
mice, we have shown that TNF-α signaling is activated in inflammatory microenvironment, 
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and plays a tumor promoting role by inducing Noxo1 in tumor cells.  Taken together, these 
results indicate that regulation of chronic inflammation in tumor tissues would be an effective 




It has been shown that chronic inflammatory diseases are associated with malignant 
diseases.  For example, reflux esophagitis, inflammatory bowel disease, ulcerative colitis, 
and chronic pancreatitis are linked to cancers of the esophagus, colon and pancreas, 
respectively.  Moreover, chronic infections with Helicobacter pylori, hepatitis viruses or 
papilloma viruses are associated with gastric cancer, hepatocellular carcinoma and cervical 
cancer, respectively.  These findings indicate that chronic inflammation and infection are 
important risk factors for cancer development.  Among the various inflammatory signaling 
pathways, mouse genetic studies and clinical studies have indicated that prostaglandin E2 
(PGE2) signaling plays an essential role in inflammation and cancer development.  In this 
chapter, we discuss the role of PGE2-associated inflammation and the role of the TNF-α 
induced by the PGE2-related microenvironment in gastric and intestinal cancer development, 
which were elucidated by mouse genetic studies. 
 
2. Non-steroidal anti-inflammatory drugs (NSAIDs) and cancer development 
Epidemiological studies indicated that the incidence and mortality rates of colorectal 
cancer were decreased significantly in population who takes aspirin, one of the NSAIDs, 
compared with non-aspirin users (Thun et al. 1993).  These results strongly suggested that 
inflammation is not just associated with cancer, but that it actually promotes cancer 
development.  The target molecules of NSAIDs are cyclooxygenase (COX)-1 and COX-2, 
which are the rate-limiting enzymes for prostaglandin (PG) biosynthesis.  COX-1 is 
constitutively expressed in most tissues, and is responsible for the physiological basal level of 
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prostaglandin production, whereas COX-2 expression is induced in inflamed tissues and 
plays a critical role in inflammatory responses.  COX-2 catalyzes the synthesis of PGH2 from 
arachidonic acid, which is further converted to PGE2 by mPGES-1.  Notably, the expression 
of COX-2 and mPGES-1 is induced simultaneously in both inflammatory and cancer tissues, 
including colon cancer and gastric cancer.  These results strongly suggested that COX-2 and 
the downstream product, PGE2, are important for cancer development through the induction 
and maintenance of inflammatory responses (Wang and DuBois 2010). 
 
3. The COX-2/PGE2 pathway and intestinal tumorigenesis 
It is well established that the accumulation of mutations in oncogenes and tumor 
suppressor genes causes cancer development and malignant progression, which is known as 
“multistep tumorigenesis”.  Among these cancer-related genes, an APC gene mutation is 
found in more than 80% of colon cancer cells, and is responsible for the initial step of 
tumorigenesis, i.e. the development of adenomatous polyps in the intestine.  We have 
previously constructed Apc gene mutant mice, Apc∆716 mice, which develop numerous polyps 
in the entire intestinal tract (Oshima et al. 1995).  In the Apc∆716 mouse polyp tissues, COX-2 
expression is induced in stroma cells, including both macrophages and fibroblasts (Sonoshita 
et al. 2002).  Accordingly, the tumor microenvironment consisting of COX-2-expressing 
stromal cells comprises the early stage of tumorigenesis.  The expression of mPGES-1 is 
also induced in the tumor stroma, indicating that PGE2 is produced in the microenvironment 
of tumor tissues (Fig. 1).   
Importantly, disruption of the COX-2 gene or treatment with COX-2-selective inhibitors 
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resulted in significant suppression of the polyp formation in Apc∆716 mice (Oshima et al. 1996; 
Oshima et al. 2001).  Consistently, disruption of the mPGES-1 gene also suppressed 
intestinal polyposis in other Apc gene mutant mice (Nakanishi et al. 2008).  Moreover, 
blocking PGE2 signaling through the EP2 receptor led to significant suppression of polyp 
formation in Apc∆716 mice (Sonoshita et al. 2001).  These results clearly indicate that the 
induction of COX-2/PGE2 signaling in the microenvironment is required for tumor 
development.   
Many studies have shown the functions of PGE2 in tumorigenesis; i.e., angiogenesis 
through the induction of VEGF and bFGF (Seno et al. 2002), and suppression of apoptosis by 
the activation of PPARδ (Wang et al. 2004).  Moreover, PGE2 signaling induces DNA 
methylation that silences tumor suppressor and DNA repair genes (Xia et al. 2012) (Fig. 1).  
However, the main mechanism by which PGE2 promotes cancer is still unclear.  We have 
constructed a new mouse model, K19-C2mE mice, which express COX-2 and mPGES-1 
simultaneously in the stomach, which induces chronic PGE2-associated inflammation in the 
gastric mucosa (Oshima et al. 2004) (Fig. 2).  Therefore, one of the important mechanisms 
by which the COX-2/PGE2 pathway is involved in tumorigenesis is by generating an 
inflammatory microenvironment. 
 
4. NF-κB signaling and inflammation-associated colon cancer 
In the tissue exposed to chronic inflammation, lipid mediators like PGE2, chemokines and 
cytokines are induced, resulting in the recruitment of bone marrow-derived cells such as 
macrophages, and activation of these cells leads to the development of a cytokine network.  
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Several transcription factors, such as NF-κB and Stat3, are activated in the inflammatory 
lesions.  NF-κB is activated by TNF-α signaling and Stat3 is activated by IL-6/IL-11, and 
these transcription factors both play a role in tumor promotion (Oshima and Oshima 2012).  
The role of Stat3 induction by IL-6 or IL-11 in intestinal tumorigenesis has been shown by 
genetic studies (Bollrath et al. 2009; Grivennikov et al. 2009; Putoczki et al. 2013).  In this 
chapter, we discuss the role of NF-κB in the promotion of colon cancer development. 
The treatment of mice with chemical mutagen azoxymethane (AOM) induces β-catenin 
gene mutations, and treatment with dextran sodium sulfate (DSS) in the drinking water 
induces ulcerative colitis.  It is well established mouse model of colitis-associated colon 
cancer can be induced by treatment with a combination of AOM and DSS.  Genetic 
inactivation of NF-κB in the bone marrow cells of AOM/DSS-treated mice resulted in a 
decrease in the growth factor expression by stromal cells and suppression of colon tumor 
development (Greten et al. 2004).  Notably, inactivation of NF-κB in intestinal epithelial cells 
also suppressed colon tumor development by leading to decreased expression of 
anti-apoptotic factors.  These results indicate that inflammatory responses promote 
tumorigenesis through the activation of NF-κB in both bone marrow-derived cells, as well as 
tumor epithelial cells, by inducing the expression of growth factors and suppressing apoptosis 
(Fig. 1). 
Recently, it has been reported that NF-κB is important for the stem cell phenotype.  
Normal intestinal epithelial cells on villi are terminally differentiated and never proliferate.  
When Wnt signaling is activated in mouse villous epithelial cells by conditional mutagenesis in 
the β-catenin gene, the cells do not proliferate, indicating that Wnt activation cannot reset the 
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terminal differentiation.  However, if NF-κB is activated together with Wnt, the epithelial cells 
acquire stem cell properties and start proliferating (Schwitalla et al. 2013a).  These results 
suggest that inflammatory responses contribute to the development or maintenance of an 
undifferentiated status or stemness of cancer cells through NF-κB activation. 
Although infection contributes to the development of an inflammatory microenvironment, 
it has not been elucidated how chronic inflammation is induced in non-infectious cancer 
tissues.  Recent results have suggested the possibility that there may be oncogene-induced 
inflammation in tumor tissues.  A loss or mutation of the p53 gene accelerates NF-κB 
activation in the microenvironment, resulting in an acceleration of colitis-associated tumor 
development in a mouse model (Schwitalla et al. 2013b; Cooks et al. 2013).  Moreover, 
KRAS mutation causes TBK1-dependent NF-κB activation, which is required for the survival 
of cancer cells (Barbie et al. 2009).  Accordingly, genetic alterations in oncogenes or tumor 
suppressor genes promote tumorigenesis not only by its intrinsic oncogenic activations, but 
also by inducing inflammatory responses. 
 
5. Gan mice, a model of inflammation-associated gastric cancer 
Helicobacter pylori infection is strongly associated with the development of gastric cancer.  
H. pylori infection induces activation of the COX-2/PGE2 pathway, which plays a role in 
infection-associated gastritis.  We have constructed transgenic K19-Wnt1 mice that express 
Wnt1, a ligand for canonical Wnt signaling, specifically in the gastric epithelial cells (Oshima 
et al. 2006; Oshima et al. 2009).  These K19-Wnt1 mice develop small preneoplastic lesions 
in the gastric mucosa, but they do not develop tumors (Fig. 2).  We crossed K19-Wnt1 mice 
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and K19-C2mE mice to induce activation of both Wnt signaling and the COX-2/PGE2 pathway 
simultaneously in the stomach (Oshima et al. 2006; Oshima et al. 2009).  Importantly, these 
double transgenic mice, Gan mice, develop large gastric tumors with a 100% incidence, 
indicating that the cooperation of Wnt signaling and the COX-2/PGE2 pathway causes gastric 
tumor development (Fig. 2).  Moreover, the gene expression profiles of Gan mouse tumor 
tissues are similar to those of human intestinal-type gastric cancer (Itadani et al. 2009).  
Accordingly, it can be concluded that Gan mice develop gastric cancer by the same 
mechanism as human gastric cancer; the induction of oncogenic activation and inflammatory 
responses, and the expression profiles also reflect those of human gastric cancer.   
 
6. TNF-α signaling in Gan mouse gastric tumorigenesis 
In the gastric tumors of Gan mice, macrophages infiltrate into the tumor stroma, and they 
are activated to express proinflammatory cytokines, chemokines, growth factors and 
proteases (Oshima et al. 2011a).  We found that the expression of EGFR ligands, including 
amphiregulin and epiregulin, and ADAM family proteases, is upregulated in Gan mouse 
tumors by an inflammation-dependent mechanism (Oshima et al. 2011b).  The ADAM family 
proteases activate EGFR ligands by exodomain shedding, resulting in the activation of EGFR 
signaling, which may be one of the mechanisms by which inflammation leads to tumor 
promotion. 
Among the various proinflammatory cytokines, we have been focusing on TNF-α, 
because it has been shown that disruption of TNF-α or the TNR-α receptor gene resulted in 
suppression of chemical carcinogen-induced tumor development in mouse models (Oshima 
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et al. 2013).  To examine the role of TNF-α in gastric tumorigenesis, we crossed Gan mice 
with TNF-α gene (Tnf) knockout mice to generate Tnf-/- Gan mice (Oshima et al. 2013).  
Notably, gastric tumorigenesis was significantly suppressed in Tnf-/- Gan mice, and the tumor 
volume decreased to 18% of the size of the tumors in the Tnf wild-type Gan mice (Fig. 3).  
Notably, COX-2 and mPGES-1 are constitutively expressed in the Tnf-/- Gan mouse stomach 
because they are expressed by exogenous promoters, thus, it is possible that TNF-α 
signaling is required for tumor promotion even if the PGE2 pathway is activated. 
Of note, bone marrow transplantation into X-ray-irradiated Tnf-/- Gan mice from wild-type 
mice rescued the gastric tumor phenotype, indicating that the TNF-α expressed by bone 
marrow-derived cells (BMDCs) is important for tumor promotion (Oshima et al. 2013).  
Furthermore, bone marrow transplantation into Gan mice from TNF-α receptor TNFR1 gene 
knockout mice resulted in significant suppression of the gastric tumor growth.  Taken 
together, these results indicate that macrophage-derived TNF-α promotes gastric 
tumorigenesis by stimulating BMDCs in the tumor microenvironment in an autocrine or 
paracrine manner (Fig. 4).  It has also been reported that TNF-α stimulates cancer cells 
directly, thus leading to the induction of IL-6 and CXCL12, and resulting in an inflammatory 
network (Kulbe et al. 2012).  Therefore, it is conceivable that TNF-α promotes tumorigenesis 
by stimulating both stromal BMDCs and cancer cells. 
 
7. Maintenance of the undifferentiated status of cancer cells by inflammation 
A microarray analysis using tumor tissues developed in Tnf-/- Gan mice and Tnf wild-type 
Gan mice revealed that over 150 genes are upregulated in the tumor tissues in a 
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TNF-α-dependent manner (Oshima et al. 2013).  Interestingly, the genes specific for 
intestinal stem cells, such as CD44, CD133 and SOX9, were included in the upregulated 
genes, suggesting that TNF-α signaling in BMDCs plays a role in the maintenance of the 
undifferentiated status of tumor cells.  By siRNA screening, we selected candidate genes 
that are important for tumorigenesis (Oshima et al. 2013).  Among these genes, the inhibition 
of Noxo1 expression resulted in significant suppression of the tumorigenicity of gastric cancer 
cell lines.  Noxo1 is a component of the NADPH oxidase NOX1 complex that regulates 
reactive oxygen species (ROS) production.  A recent report indicated that Rac1, another 
member of the NOX1 complex, is activated by Wnt signaling in the intestinal tumor cells, and 
that Rac1 activation is required for the undifferentiated status of tumor cells induced by ROS 
production together with NF-κB activation (Myant et al. 2013).  Moreover, Noxo1 expression 
is upregulated also in the normal gastric epithelial stem cells, suggesting a role of Noxo1 in 
maintenance of stem cells (Barker et al. 2010).  These results strongly suggest that TNF-α 
signaling promotes tumor development by regulating the maintenance of the undifferentiated 
status of tumor cells through Noxo1 induction-associated ROS production. 
 
8. Conclusion 
The COX-2/PGE2 pathway is induced in most cancer tissues, and it has been established 
that PGE2 plays an important role in cancer development.  PGE2 promotes tumor 
development through a variety of mechanisms, including the development of an inflammatory 
microenvironment.  Accumulating evidence has indicated that activation of NF-κB, an 
important transcription factor involved in inflammation, is also essential for tumor promotion 
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via its induction of growth factors, protection of tumor cells from apoptosis and acquisition of 
stem cell properties.  Moreover, the TNF-α that is induced in the inflammatory 
microenvironment is required for tumor promotion.  TNF-α activation in the BMDCs in the 
tumor stroma induces Noxo1 expression in tumor cells, which may be important for the 
maintenance of the undifferentiated status of tumor cells by ROS production. Taken together, 
these results indicate that the regulation of PGE2-associated inflammatory responses and 
TNF-α signaling may be an effective preventive or therapeutic strategy against the 
development of gastrointestinal cancer. 
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Figure 1. A schematic drawing of the inflammatory microenvironment in gastrointestinal 
tumors.  The COX-2/PGE2 pathway is important for the development and maintenance of 
the inflammatory microenvironment, including BMDCs.  PGE2 signaling also accelerates 
angiogenesis, cell survival as well as induces DNA methylation.  In the activated 
macrophages, NF-κB induces the expression of growth factors and cytokines.  The 
activation of NF-κB and Stat3 in tumor cells suppresses the apoptosis of tumor cells.  NF-κB 
activation also induces the acquisition of stem cell properties. (Modified from Oshima and 
Oshima, 2012 with permission from Springer) 
 
Figure 2. Transgenic mouse models used to examine gastric tumorigenesis.  Transgenic 
vector constructs and representative macroscopic and microscopic photographs of the 
stomach are shown for each line.  Gan mice are compound K19-Wnt1 and K19-C2mE 
transgenic mice.  The arrowhead in the K19-Wnt1 mouse stomach indicates a preneoplastic 
lesion.  The arrowheads in the K19-C2mE mouse stomach indicate inflammatory infiltration.  
The arrows in the Gan mouse indicate gastric tumors.  Bars indicate 100 µm.  (Modified 
from Oshima et al, 2009 with permission from Wiley) 
 
Figure 3. Suppression of gastric tumor development by TNF-α gene disruption.  (a) 
Representative histological photographs of whole views of Tnf+/+ Gan (top) and Tnf-/- Gan 
mouse (bottom) gastric tumors (H&E).  The arrows indicate suppressed tumor lesions in 
Tnf-/- Gan mice.  Bars indicate 5 mm.  (b) The gastric tumor size of Tnf+/+ Gan, Tnf+/- Gan 
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and Tnf-/- Gan mice relative to the mean level of Tnf+/+ Gan mouse tumors (set at 100%).  
Asterisks, P < 0.05.  (Reproduced from Oshima H, 2013 with permission from Nature 
Publishing Group) 
 
Figure 4. A schematic drawing of the role of TNF-α signaling in gastric tumorigenesis.  
BMDCs, including macrophages, are recruited to the inflammatory microenvironment and 
express TNF-α, which further activates the TNFR1 receptor on BMDCs, which is important for 
inducing tumor-promoting factors, including Noxo1, in tumor epithelial cells.  Noxo1 
expression may induce ROS production, which is required for the undifferentiated status of 
tumor cells.  (Reproduced from Oshima H, 2013 with permission from Nature Publishing 
Group) 
 
 




